World's Best Scientists 2026 revealed!
Sepehr N. Tabrizi

Sepehr N. Tabrizi

D-Index & Metrics

Microbiology

D-Index
76
Citations
18017
World Ranking
1440
National Ranking
43

Medicine

D-Index
76
Citations
18553
World Ranking
18886
National Ranking
635

Sepehr N. Tabrizi publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Sepehr N. Tabrizi sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 384 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Sepehr N. Tabrizi D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Sepehr N. Tabrizi sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 76 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Sepehr N. Tabrizi is affiliated with the University of Melbourne in Australia. Their research primarily spans the field of medicine, with a focus on subfields such as epidemiology, surgery, microbiology, pediatrics, perinatology, child health, and general health professions.

Tabrizi's scholarly output includes significant work in topics like cervical cancer and HPV research, genital health and disease, hepatitis B virus studies, colorectal and anal carcinomas, reproductive tract infections, global maternal and child health, and microbial infections and disease research.

Their recent papers include:

  • The Natural History of Anal High-grade Squamous Intraepithelial Lesions in Gay and Bisexual Men (2020, Clinical Infectious Diseases)
  • Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study (2021, The Lancet Infectious Diseases)
  • Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT) (2022, The Lancet Global Health)
  • Gene methylation of CADM1 and MAL identified as a biomarker of high grade anal intraepithelial neoplasia (2022, Scientific Reports)
  • A custom amplicon sequencing approach to detect resistance associated mutations and sequence types in Mycoplasma genitalium (2020, Journal of Microbiological Methods)

Frequent coauthors in Tabrizi's work are:

  • Suzanne M. Garland (24 collaborations)
  • Alyssa M. Cornall (15 collaborations)
  • Christopher K. Fairley (11 collaborations)
  • Gerald L. Murray (9 collaborations)
  • Dorothy A. Machalek (7 collaborations)

Tabrizi's research has been published predominantly in the following venues:

  • Clinical Infectious Diseases (4 publications)
  • Vaccine (3 publications)
  • The Lancet Global Health (2 publications)
  • SSRN Electronic Journal (2 publications)
  • The Journal of Infectious Diseases (2 publications)

Best Publications

  • Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis

    Dorothy A Machalek;Mary Poynten;Fengyi Jin;Christopher K Fairley

  • Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

    Melanie Drolet;Elodie Benard;Marie-Claude Boily;Marie-Claude Boily;Hammad Ali

  • Web-Based Recruiting for Health Research Using a Social Networking Site: An Exploratory Study

    Yeshe Fenner;Suzanne M Garland;Elya E Moore;Yasmin Jayasinghe

  • Azithromycin Treatment Failure in Mycoplasma genitalium–Positive Patients with Nongonococcal Urethritis Is Associated with Induced Macrolide Resistance

    Jørgen S. Jensen;Catriona S. Bradshaw;Catriona S. Bradshaw;Sepehr N. Tabrizi;Sepehr N. Tabrizi;Christopher K. Fairley;Christopher K. Fairley

  • The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy.

    Catriona S Bradshaw;S N Tabrizi;S N Tabrizi;Christopher K Fairley;Anna N Morton

  • Fall in Human Papillomavirus Prevalence Following a National Vaccination Program

    Sepehr N Tabrizi;Julia Brotherton;John M Kaldor;S Rachel Skinner

  • Etiologies of Nongonococcal Urethritis: Bacteria, Viruses, and the Association with Orogenital Exposure

    Catriona S. Bradshaw;Sepehr N. Tabrizi;Sepehr N. Tabrizi;Timothy R. H. Read;Suzanne M. Garland;Suzanne M. Garland

  • Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study

    Sepehr N Tabrizi;Julia Brotherton;John Martin Kaldor;S Rachel Skinner

  • Probiotic Effects on Late-onset Sepsis in Very Preterm Infants: A Randomized Controlled Trial

    Susan E. Jacobs;Jacinta M. Tobin;Gillian F. Opie;Susan Donath

  • Azithromycin Failure in Mycoplasma genitalium Urethritis

    Catriona Susan Bradshaw;Jorgen Jensen;Sepehr N Tabrizi;Timothy R H Read

  • Macrolide Resistance and Azithromycin Failure in a Mycoplasma genitalium–Infected Cohort and Response of Azithromycin Failures to Alternative Antibiotic Regimens

    Melanie Bissessor;Sepehr N. Tabrizi;Jimmy Twin;Houda Abdo

  • Hormonal Contraception Is Associated with a Reduced Risk of Bacterial Vaginosis: A Systematic Review and Meta-Analysis

    Lenka A. Vodstrcil;Lenka A. Vodstrcil;Jane S. Hocking;Matthew Law;Sandra Walker;Sandra Walker

  • Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium

    Gerald L. Murray;Catriona S. Bradshaw;Melanie Bissessor;Jennifer A Danielewski

  • Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas.

    Janet Knox;Sepehr N Tabrizi;Penny Miller;Kathy Petoumenos

  • Azithromycin Versus Doxycycline for the Treatment of Genital Chlamydia Infection: A Meta-analysis of Randomized Controlled Trials

    Fabian Yuh Shiong Kong;Sepehr Tabrizi;Matthew Law;Lenka A Vodstrcil

  • Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination

    Dorothy A Machalek;Dorothy A Machalek;Suzanne M Garland;Julia M L Brotherton;Deborah Bateson

  • Evaluation of Six Commercial Nucleic Acid Amplification Tests for Detection of Neisseria gonorrhoeae and Other Neisseria Species

    Sepehr N. Tabrizi;Magnus Unemo;Athena E. Limnios;Tiffany R. Hogan

  • A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program.

    Daniel Novakovic;Alan T L Cheng;Yvonne Zurynski;Robert Booy

  • Chlamydia trachomatis incidence and re-infection among young women – behavioural and microbiological characteristics

    Jennifer Walker;Sepehr N. Tabrizi;Christopher K. Fairley;Marcus Y. Chen

  • Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis.

    Jimmy Twin;Jorgen Jensen;Catriona Bradshaw;Catriona Bradshaw;Catriona Bradshaw;Suzanne Marianne Garland

  • Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study

    Eric P F Chow;Dorothy A Machalek;Sepehr N Tabrizi;Sepehr N Tabrizi;Jennifer A Danielewski

Frequent Co-Authors

Suzanne M. Garland
Suzanne M. Garland University of Melbourne
Christopher K. Fairley
Christopher K. Fairley Monash University
Catriona S. Bradshaw
Catriona S. Bradshaw Monash University
John M. Kaldor
John M. Kaldor University of New South Wales
Andrew E. Grulich
Andrew E. Grulich University of New South Wales
Julia M.L. Brotherton
Julia M.L. Brotherton University of Melbourne
Eric P F Chow
Eric P F Chow Monash University
Michael A. Quinn
Michael A. Quinn International Gynaecological Cancer Society
David M. Whiley
David M. Whiley University of Queensland
John D. Wark
John D. Wark University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Microbiology can open diverse career opportunities in healthcare and research. Many students consider online healthcare degrees to expand their knowledge while balancing other commitments. These programs often provide flexible schedules and specialized tracks that complement a background in microbiology.

Public health is another popular route, and some students look for the easiest MPH online programs to get into. These master's degrees equip graduates with essential skills in epidemiology and disease prevention, making them valuable assets in both public and private sectors.

For those interested in applying their scientific understanding in more specialized roles, careers such as child life specialists offer meaningful work. Understanding how much do child life specialists make can help prospective students evaluate the financial prospects of this career path.

Additionally, individuals with unique backgrounds might explore alternative entry points into healthcare through degrees designed for accessibility, such as the best associate degrees for felons. These programs help break barriers and create more inclusive pathways into meaningful professions, often including microbiology-related roles.

Best Scientists Citing Sepehr N. Tabrizi

Trending Scientists

Recently Published Articles